Tác giả: Peter J. Neumann

As health costs in the U.S. soar past $1.5 trillion, much evidence indicates that the nation does not get good value for its money. It is widely agreed that we could do better by using cost-effective …

A COMPLETE UPDATE AND REVISION OF THE CLASSIC TEXT"At last, a manual of operations for comparing the cost-effectiveness of a preventive service with a treatment intervention." –American Jo …

A COMPLETE UPDATE AND REVISION OF THE CLASSIC TEXT"At last, a manual of operations for comparing the cost-effectiveness of a preventive service with a treatment intervention." –American Jo …

The US prescription drug business is a $500 billion industry whose rising prices carry profound consequences for patients, caregivers, employers and taxpayers across the nation. In the United States, …

The US prescription drug business is a $500 billion industry whose rising prices carry profound consequences for patients, caregivers, employers and taxpayers across the nation. In the United States, …

As health costs in the U.S. soar past $1.5 trillion, much evidence indicates that the nation does not get good value for its money. It is widely agreed that we could do better by using cost-effective …